Table2_Variable clinical expression of a Belgian TGFB3 founder variant suggests the presence of a genetic modifier.DOCX

Background:TGFB3 variants cause Loeys–Dietz syndrome type 5, a syndromic form of thoracic aortic aneurysm and dissection. The exact disease phenotype is hard to delineate because of few identified cases and highly variable clinical representation. Methodology: We provide the results of a haplotype analysis and a medical record review of clinical features of 27 individuals from 5 different families, originating from the Campine region in Flanders, carrying the NM_003239.5(TGFB3):c.787G>C p.(Asp263His) likely pathogenic variant, dbSNP:rs796051886, ClinVar:203492. The Asp 263 residue is essent... Mehr ...

Verfasser: Melanie H. A. M. Perik
Emmanuela Govaerts
Steven Laga
Inge Goovaerts
Johan Saenen
Emeline Van Craenenbroeck
Josephina A. N. Meester
Ilse Luyckx
Inez Rodrigus
Aline Verstraeten
Lut Van Laer
Bart L. Loeys
Dokumenttyp: Dataset
Erscheinungsdatum: 2023
Schlagwörter: Genetics / Genetic Engineering / Biomarkers / Developmental Genetics (incl. Sex Determination) / Epigenetics (incl. Genome Methylation and Epigenomics) / Gene Expression (incl. Microarray and other genome-wide approaches) / Genome Structure and Regulation / Genomics / Genetically Modified Animals / Livestock Cloning / Gene and Molecular Therapy / Loeys–Dietz syndrome (LDS) / TGFB3 / thoracic aortic aneurysm and dissection (TAAD) / founder / genetic modifiers / connective tissue disorder / variable expressivity
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-28886845
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3389/fgene.2023.1251675.s002

Background:TGFB3 variants cause Loeys–Dietz syndrome type 5, a syndromic form of thoracic aortic aneurysm and dissection. The exact disease phenotype is hard to delineate because of few identified cases and highly variable clinical representation. Methodology: We provide the results of a haplotype analysis and a medical record review of clinical features of 27 individuals from 5 different families, originating from the Campine region in Flanders, carrying the NM_003239.5(TGFB3):c.787G>C p.(Asp263His) likely pathogenic variant, dbSNP:rs796051886, ClinVar:203492. The Asp 263 residue is essential for integrin binding to the Arg-Gly-Asp (RGD) motif of the TGFβ3-cytokine. Results: The haplotype analysis revealed a shared haplotype of minimum 1.92 Mb and maximum 4.14 Mb, suggesting a common founder originating >400 years ago. Variable clinical features included connective tissue manifestations, non-aneurysmal cardiovascular problems such as hypertrophic cardiomyopathy, bicuspid aortic valve, mitral valve disease, and septal defects. Remarkably, only in 4 out of the 27 variant-harboring individuals, significant aortic involvement was observed. In one family, a 31-year-old male presented with type A dissection. In another family, the male proband (65 years) underwent a Bentall procedure because of bicuspid aortic valve insufficiency combined with sinus of Valsalva of 50 mm, while an 80-year-old male relative had an aortic diameter of 43 mm. In a third family, the father of the proband (75 years) presented with ascending aortic aneurysm (44 mm). Conclusion: The low penetrance (15%) of aortic aneurysm/dissection suggests that haploinsufficiency alone by the TGFB3 variant may not result in aneurysm development but that additional factors are required to provoke the aneurysm phenotype.